Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer.
Hiroaki InoueRie HoriiYoshinori ItoTakuji IwaseShinji OhnoFutoshi AkiyamaPublished in: Breast cancer (Tokyo, Japan) (2017)
TILs are associated with the efficacy of trastuzumab-based treatment in HER2-positive breast cancer.